Also trades as: NGLFINE.NS (NSE) · $vol 1M
NGLFINE.BO BSE
NGL Fine-Chem Limited
1W: +1.0%
1M: +8.9%
3M: -10.2%
YTD: +31.2%
1Y: +118.6%
3Y: +51.4%
₹2,876.50 ($29.88)
-49.00 (-1.67%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#8
of 10
Drug Manufacturers - General
Technical Signal Map
6 Bullish
0 Neutral
5 Bearish
NGLFINE.BO
$18B
NGL Fine-Chem Limited
BULLISH
+68
SMSPHARMA.NS
$44B
SMS Pharmaceuticals Limited
BULLISH
+100
KOPRAN.NS
$14B
Kopran Limited
BULLISH
+82
ABBOTINDIA.NS
$571B
Abbott India Limited
BULLISH
+78
NGLFINE.NS
$18B
NGL Fine-Chem Limited
BULLISH
+68
MARKSANS.NS
$148B
Marksans Pharma Limited
LEAN BULL
+24
GLAXO.NS
$469B
GlaxoSmithKline Pharmaceuticals Limited
BEARISH
-34
SENORES.NS
$62B
Senores Pharmaceuticals Ltd.
BEARISH
-75
TTKHLTCARE.NS
$14B
TTK Healthcare Limited
BEARISH
-75
PFIZER.NS
$177B
Pfizer Limited
BEARISH
-91
SANOFICONR.NS
$87B
Sanofi Consumer Healthcare India Ltd.
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| NGLFINE.BO NGL Fine-Chem Limited | $18B | 31.4 | 15.7 | 10.1 | 9.0 | 36.1 | 4 | BULLISH | 118.6 |
| SMSPHARMA.NS SMS Pharmaceuticals Limited | $44B | 43.0 | 14.3 | 9.3 | 13.7 | 13.3 | 7 | BULLISH | 101.9 |
| KOPRAN.NS Kopran Limited | $14B | 54.2 | 4.9 | 6.7 | 8.1 | 8.2 | 5 | BULLISH | 81.7 |
| ABBOTINDIA.NS Abbott India Limited | $571B | 35.1 | 34.5 | 50.4 | 23.1 | 8.1 | 6 | BULLISH | -18.5 |
| NGLFINE.NS NGL Fine-Chem Limited | $18B | 31.4 | 15.7 | 10.1 | 9.0 | 36.1 | 4 | BULLISH | 121.2 |
| MARKSANS.NS Marksans Pharma Limited | $148B | 28.7 | 15.2 | 15.8 | 17.3 | 12.5 | 6 | LEAN BULL | 82.3 |
| GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited | $469B | 43.8 | 49.1 | -201.0 | 27.9 | 2.6 | 5 | BEARISH | -0.1 |
| SENORES.NS Senores Pharmaceuticals Ltd. | $62B | — | — | — | — | — | — | BEARISH | 99.9 |
| TTKHLTCARE.NS TTK Healthcare Limited | $14B | 19.6 | 6.0 | 6.8 | 10.0 | 7.0 | 4 | BEARISH | -10.4 |
| PFIZER.NS Pfizer Limited | $177B | 23.9 | 17.2 | 59.2 | 31.8 | 10.4 | 6 | BEARISH | -32.3 |
| SANOFICONR.NS Sanofi Consumer Healthcare India Ltd. | $87B | 32.5 | 17.3 | 189.0 | 26.5 | — | 4 | BEARISH | -28.3 |
| NGLFINE.BO NGL Fine-Chem Limited | $18B | 31.4 | 15.7 | 10.1 | 9.0 | 36.1 | 4 | BULLISH | 118.6 |
| SMSPHARMA.NS SMS Pharmaceuticals Limited | $44B | 43.0 | 14.3 | 9.3 | 13.7 | 13.3 | 7 | BULLISH | 101.9 |
| KOPRAN.NS Kopran Limited | $14B | 54.2 | 4.9 | 6.7 | 8.1 | 8.2 | 5 | BULLISH | 81.7 |
| ABBOTINDIA.NS Abbott India Limited | $571B | 35.1 | 34.5 | 50.4 | 23.1 | 8.1 | 6 | BULLISH | -18.5 |
| NGLFINE.NS NGL Fine-Chem Limited | $18B | 31.4 | 15.7 | 10.1 | 9.0 | 36.1 | 4 | BULLISH | 121.2 |
| MARKSANS.NS Marksans Pharma Limited | $148B | 28.7 | 15.2 | 15.8 | 17.3 | 12.5 | 6 | LEAN BULL | 82.3 |
| GLAXO.NS GlaxoSmithKline Pharmaceuticals Limited | $469B | 43.8 | 49.1 | -201.0 | 27.9 | 2.6 | 5 | BEARISH | -0.1 |
| SENORES.NS Senores Pharmaceuticals Ltd. | $62B | — | — | — | — | — | — | BEARISH | 99.9 |
| TTKHLTCARE.NS TTK Healthcare Limited | $14B | 19.6 | 6.0 | 6.8 | 10.0 | 7.0 | 4 | BEARISH | -10.4 |
| PFIZER.NS Pfizer Limited | $177B | 23.9 | 17.2 | 59.2 | 31.8 | 10.4 | 6 | BEARISH | -32.3 |
| SANOFICONR.NS Sanofi Consumer Healthcare India Ltd. | $87B | 32.5 | 17.3 | 189.0 | 26.5 | — | 4 | BEARISH | -28.3 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
NGLFINE.BO vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F